In The News

IP Litigators Analyze Section 112 Biopharma Post-Grant Review Patent Challenges

Practices: Intellectual Property, Intellectual Property Litigation, Patent Strategy, Patent Trial & Appeal Board (PTAB) Proceedings, Life Sciences, Technology, Media & Telecommunications, Litigation

Capital Insights.

In the Kluwer Patent Blog, IP litigation partners Charlotte Jacobsen, Filko Prugo and associate Meredith Foor (all of New York) analyzed trends in Section 112 challenges in Post-Grant Reviews at the Patent Trial and Appeal Board, an important issue for biotechnology, pharmaceutical and chemical patent invalidity claims.

Cookie Settings